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INTRODUCTION: Ossifying ﬁbromyxoid tumor (OFMT) is an uncommon soft tissue and bone neoplasm
with just over 100 cases being reported in the literature. They present as small, slow-growing asymp-
tomatic subcutaneous nodules in the soft tissues of the trunk and extremities.
PRESENTATION OF CASE: We present a case of a 25-year-old, right hand dominant gentleman who com-
plained of a seven-year history of pain and discomfort in the dorsal aspect of the right thumb. He was
unable to move his interphalangeal joint (IPJ) but had good function otherwise. Examination revealed
a localized tender swelling over the dorsal aspect of the IPJ. The thumb was ﬁxed in extension. X-ray
revealedmarked abnormal soft tissue swelling around the interphalangeal joint, cystic abnormalities and
new bone formation. Biopsy showed ﬁbrous tissue containing nodules of tumor with cells in a myxoid
background, rounded and histiocytoid to elongated and spindle shaped. CD57, type IV collagen, smooth
muscle actin were found and CD56 and EMA were focally positive.
These were in keeping with ossifying ﬁbromyxoid tumor with an atypical immunophenotype.
DISCUSSION: The tumorwas formally excisedwith the ﬂexor pollicis longus tendon. A two-month review
revealed his pain had settled. As the tumor had an atypical immunophenotype he was referred to the
regional sarcoma team.
CONCLUSION:OMFT canpresentwith atypical clinical, radiological andhistological features. It ismanaged
in a multidisciplinary setting and often requires lifetime follow up to detect a recurrence given the
uncertain nature of these lesions.
© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Ossifying ﬁbromyxoid tumors (OFMT) are rare tumors of
unknown origin. They often present with non-speciﬁc pain in the
extremities. The rarity of the lesion and its atypical features may
result in delayed diagnosis and challenges in patient management.
We describe a case of atypical OFMT with unique histological and
radiological ﬁndings. We have also discussed management strate-
gies of the various types of OMFT on the basis of it being a subset
of upper limb sarcomas.
2. Case report
A 25-year old Nigerian man experienced seven years of gradu-
ally increasing pain and discomfort in his dominant right thumb,
post injury in amartial arts competition. Hewas treated by an allo-
pathic Doctor in his homeland prior to being seen in the United
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Kingdom. Clinically he presented with an intermittent ache along
the dorsal aspect of his thumb, which woke him at night. He was
unable to move his interphalangeal joint (IPJ) but had good func-
tion. Examination revealed a localized tender swelling beneath a
scar over the dorsal aspect of the IPJ. The thumbwas ﬁxed in exten-
sion.
X-ray revealedmarked abnormal soft tissue swelling around the
interphalangeal joint, cystic abnormalities andnewbone formation
adjacent to the head of the proximal phalanx of his right thumb
(Fig. 1). Biopsy macroscopically revealed a mass of scar/ﬁbrotic
tissue surrounding the IPJ. Microscopy revealed ﬁbrous tissue con-
taining nodules of tumor tissue divided by ﬁbrous septa of varying
thickness. The tumor consisted of a variably dense population of
cells in a myxoid background, the shapes of which were rounded
and histiocytoid to elongated and spindle shaped. CD57, type IV
collagen, smoothmuscle actinwere found and CD56 and EMAwere
focally positive (Fig. 2). These features were in keeping with ossi-
fying ﬁbromyxoid tumor with an atypical immunophenotype. Two
months following his biopsy he reported pain on the volar aspect of
his thumb. MRI scan revealed a tumor with myxoid content within
the soft tissues of the volar aspect of the proximal phalanx of
the thumb extending across the interphalangeal joint. The tumor,
which presented macroscopically as dense white ﬁbrous tissue,
http://dx.doi.org/10.1016/j.ijscr.2014.10.099
2210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. X-rays (AP and lateral) demonstrating abnormal soft tissue swelling around
the interphalangeal joint, cystic abnormalities and new bone formation adjacent to
the head of the proximal phalanx.
was formally excised with the ﬂexor pollicis longus tendon as it
was seen to be invading the head of the proximal phalanx (Fig. 3).
Further histological analysis revealed ovoid or short spindle cells
in nests and variable myxoid change. Other immunostains found
included MUC4, calponin, h-caldesmon, CD10, D2-40. Subsequent
histology reported the tumor to be completely excised.
Two months post-operatively his pain had settled apart from
one small area dorsally. As the tumor had an atypical phenotype
he was referred to the regional sarcoma team. A multidisciplinary
team consisting of plastic surgeons, radiologists, oncologists and
the patient assessed the various options of monitoring with yearly
MRI scans, radiotherapy or amputation with toe to thumb transfer.
The patient opted for monitoring and has shown no signs of
recurrence in the past year.
3. Discussion
Ossifying ﬁbromyxoid tumor (OFMT) is an uncommon soft tis-
sue and bone neoplasm with just over 100 cases being reported
in the literature. First described by Enzinger et al. in 1989,1 they
most commonly affect middle-aged male adults with a mean age
50 years. Clinically they present as small, slow- growing asymp-
tomatic subcutaneous nodules in the soft tissues of the trunk and
extremities.2 Histological analysis of typical cases reveals lobules of
small ovoid to polygonal bland cells arranged in cords and/or nests
embeddedwithin aﬁbromyxoidmatrix.1,3 Abandof dense collagen
with spicules of metaplastic bone is commonly encountered at the
tumor periphery.4 Most tumors display low cellularity, lownuclear
grade, absent necrosis or vascular space invasion and low mitotic
rates. As a result they are often classiﬁed as benign to at most low
grade malignant, however several reports have documented rare
atypical and malignant variants of OFMT, with metastasis.5
Historically there has been an ongoing debate to deﬁne the
characteristics of malignancy in OMFT in order to plan follow up
and subsequent treatment for these patients. In one of the largest
series to date, Folpe et al. classiﬁed OFMTs into benign, atypical
and malignant. Aggressive OFMT was found to be associated with
high nuclear grade, cellularity and mitotic activity. These lesions
are labeled as malignant OMFT as there is signiﬁcant potential
for metastasis.6 Atypical OMFT on the other hand do not ﬁt the
appearance of typical OMFT but not meeting the criteria for malig-
nant OMFT. The overall proposed recurrence and metastatic rates
of atypical OMFT are 13% and 6% respectively hence the typical and
atypical forms of this tumor are considered as lesions of interme-
diatemalignancy.1,7,8 In our case there wasminimal nuclear atypia
and no mitotic or apoptotic cells which excluded a diagnosis of
malignant OMFT.
A subsequent case study by Graham et al. attempted to further
elucidate the natural history of OFMT and reassess the validity of
the Folpe and Weiss classiﬁcation. They examined 46 cases and
concluded that the classiﬁcation system adopted by Folpe et al. was
accurate in elucidating malignant OFMT.3
The exact origins of these tumors are unclear and debatable.
In its ﬁrst description by Enzinger a neural or cartilaginous origin
was proposed as two thirds of the cases contained the immunore-
active s-100 protein and an incomplete shell of mature bone
in the capsular region of the tumor. Hence the non- committal
Fig. 2. H&E staining showing nodules of tumor divided by ﬁbrous septa. The tumor consists of cells in a myxoid background. The pale pink area reﬂects bone formation. The
ﬁgure to the right has a magniﬁcation of ×40 and left ×100.
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Fig. 3. MRI illustrating the tumor with myxoid content within the soft tissues and bone surrounding the IPJ of the thumb.
label of ossifying ﬁbromyxoid tumor of soft parts.1 In addition to
histology, immunohistochemistry is an integral part of the
diagnostic pathway in OMFTs. In the four largest case series s100,
desmin and smoothmuscle actinwere found to bemost commonly
associatedwithOMFT. In our case immunohistochemistry revealed
cd57, type IV collage, smooth muscle actin, CD56 and EMA. This
caused a diagnostic quandary and a differential diagnosis of
myxoid perineuroma, nerve sheath myxoma and OMFT was given.
However taking into consideration the patient’s clinical picture,
radiological and histological ﬁndings, a diagnosis of atypical OMFT
was favored, as it is known to display variable immunophenotypes.
The exact management once the lesion has been excised
depends on its classiﬁcation. Folpe et al. reported a clinical follow
up of 27 cases (mixture of typical and atypical OFMT) of about 55
monthsdurationand foundall patients tobe alivewithoutdisease.6
Grahamet al. reportedno cases ofmetastasis in patientswith atypi-
cal or typical OMFT,Miettinen et al. reported no cases ofmetastases
in typical OMFT although local recurrence was present in 22% of
patients at follow up. Given the uncertain history of this rare lesion
we recommend a multidisciplinary approach to the management
of these patients. Operative intervention is often required for ade-
quate clearance of the tumor and reconstruction depending on
functional needs. As this would fall within the realm of a sarcoma
follow up would be life long consisting of clinical and radiological
assessment (MRI) for recurrence due to the uncertain malignant
potential of this rare lesion.
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